DRKS00022441
Recruiting
Not Applicable
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C73
- Sponsor
- niversitätsklinikum Freiburg
- Enrollment
- 75
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histological confirmed thyroid cancer with focus on anaplastic thyroid cancer and poorly differentiated cancer but also other thyroid cancer entities. The patients must have at least one tumor leasion that can be seen and measured in radiological assessment. They must be over 18 years old and competent.
Exclusion Criteria
- •\<18 years old. Pregnancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)C83.3C85Diffuse large B-cell lymphomaOther and unspecified types of non-Hodgkin lymphomaDRKS00024180niversitätsklinikum Freiburg200
Not yet recruiting
Not Applicable
Circulating tumor DNA as biomarker for perihilar cholangiocarcinomaPerihilar cholangiocarcinoma/ Perihilair cholangiocarcinoomKlatskin-tumorBiomarkerCirculating tumor DNA /Circulerend tumor DNA (ctDNA)NL-OMON27478AMC20
Completed
Not Applicable
Circulating tumor DNA as a biomarker in perihilar cholangiocarcinoma: a feasibility studybiliary tract cancerperihilar cholangiocarcinoma10019815NL-OMON43203Academisch Medisch Centrum20
Completed
Not Applicable
ctDNA as a Biomarker for Treatment Response in HNSCCCarcinoma, Squamous Cell of Head and NeckNCT03540563The Netherlands Cancer Institute70
Completed
Not Applicable
Prospective Evaluation of Circulating Tumour DNA (ctDNA) as Molecular Monitoring Tool and Prognostic Biomarker in Resectable Pancreatic AdenocarcinomasC25Malignant neoplasm of pancreasDRKS00010992niversitätsklinikum Freiburg25